AlphaYouMR
Insider buying
Michael R Hayden bought $570K of AbCellera Biologics Inc. (ABCL) stock
Michael R Hayden, Dir of AbCellera Biologics Inc. (ABCL), bought 53,613 shares of ABCL stock worth $570K, per an SEC Form 4 filed Aug 24, 2026.
It was an open-market purchase.
The trade was reported on Aug 24, 2026.
ABCL has moved +19.2% since the trade date, from $10.61 to $12.65 (Sep 22, 2026 close).
- Traded
- Aug 24, 2026
- Disclosed
- Aug 24, 2026
- Filing delay
- 0 days
- Price since
- +19.2%
- Role
- Dir
- Source
- SEC Form 4
More ABCL insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.